Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Tripeptides – e.g. – tripeptide thyroliberin – etc.
Reexamination Certificate
2005-07-12
2005-07-12
Weber, Jon (Department: 1653)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Tripeptides, e.g., tripeptide thyroliberin , etc.
C530S330000, C514S018700, C514S019300, C546S146000, C546S150000, C562S553000
Reexamination Certificate
active
06916905
ABSTRACT:
A compound of formula:wherein X is a spacer comprising one or more amino acid residues and Y comprises an aromatic group and related compositions and methods of use.
REFERENCES:
patent: 5780589 (1998-07-01), Lazarus et al.
patent: 5811400 (1998-09-01), Schiller
Lazarus et al., International Symposium on Peptide Chem & Biol, Changchung, PRC (1999).
Abrash et al., Biochemistry, 2(5):947-953, Sep.-Oct. (1963).
Arakawa et al., Transplantation, 53(4): 951-953, Apr. (1992).
Arakawa et al., Transplantation Pro., 24(2):696-697, Apr. (1992).
Arakawa et al., Transplantation Pro., 25(1):738-740, Feb. (1993).
Balboni et al., Biol. Chem., 378:19-29, Jan. (1997).
Borch et al., J. Org. Chem., 37(10):1673-1674 (1972).
Bryant et al., Biol. Chem, 378:107-114, Feb. (1997).
Bryant et al., Trends in Pharmacol. Sci., 18: 42-46 (1998).
Callaghan et al., J. Biol. Chem., 268(21):16059-16064, Jul. 25, (1993).
Capasso et al., Int. J. Peptide Protein Res., 45:567-573 (1995).
Carpenter et al., J. Am. Chem. Soc., 116(19):8450-8458 (1994).
Chappell, Lancet, 343:556, Mar. 5, (1994).
Crabb et al., J. Chem. Soc., Perkins Transactions II, 370-378 (1977).
Crescenzi et al., Eur. J. Biochem., 247:66-73 (1997).
Dygos et al., Synthesis, 741-743, Aug. (1992).
Ermishc et al., Phys. Rev., 73(3):489-527, Jul. (1993).
Flippen-Anderson et al., J. Peptide Res., 49:384-393 (1997).
Ford et al., Cancer Research, 50:1748-1756, Mar. 15 (1990).
Froehlich et al., Alcohol Clin. Exp. Res., 20(8):181A-186A, Nov. Supp. (1996).
Guerrini et al., Bioorg. Med. Chem., 6:57-62 (1998).
Hayashi et al., Chem. Pharm. Bull., 31(1):312-314 (1983).
House et al., Neurosci. Lett., 198:119-122 (1995).
Jones et al., J. of Pharm. Exp. Thera., 262(2):638-645 (1992).
Kertész et al., J. Labelled Cpd. and Radiopharm., XLI:1083-1091 (1998).
Lazarus et al., J. Biol. Chem., 264(1):354-362, Jan. 5 (1989).
Lazarus et al., Biochem. Biophys. Res. Comm., 178(1):110-115, Jul. 15 (1991).
Lazarus et al., Drug Devel. Today, 3(6):284-294, Jun. 6 (1998).
Lensing et al., Neuropsychobiology, 31:16-23 (1995).
Linner et al., Eur. J. of Pharmacol., 354:R3-R5 (1998).
Marsden et al., Int. J. Peptide Protein Res., 41:313-316 (1993).
Matthes et al., Nature, 383:819-823, Oct. 31 (1996).
Menkens et al., Eur. J of Pharmacol., 219:345-346 (1992).
Mosberg et al., Letters in Peptide Science, 1:69-72 (1994).
Nogae et al., Biochem. Pharmacol., 38(3):519-527 (1989).
Pearce et al., Proc. Natl. Acad. Sci. USA, 86:5128-5132, Jul. (1989).
Portoghese et al., Eur. J. Pharmacol., 146:185-186 (1988).
Ramu et al., Int. J. Cancer, 43:487-491 (1989).
Sagan et al., Biochem. Biophys. Res. Commun., 187(3):1203-1210, Sep. 30 (1992).
Salvadori, Mol. Med. 1(6):678-689, Sep. (1995).
Salvadori, J. Med. Chem., 42:5010-5019 (1999).
Schiller et al., Proc. Natl. Acad. Sci. USA, 89:11871-11875, Dec. (1992).
Schiller et al., Peptides: Chemistry, Structure and Biology; Proceedings of the Thirteenth American Peptide Symposium, pp. 483-486, Jun. 20-25 (1993), Edmonton, Alberta, Canada, ESCOM.
Schiller et al., J. Med. Chem., 36(21):3182-3187 (1993).
Schinkel, et al., J. Clin. Invest., 97(11):2517-2524, Jun. (1996).
Schinkel, Intern. J. Clin. Pharm. Therapeutics, 36(1):9-13 (1998).
Temussi et al., Biochem. Biophys. Res. Commun., 198(3):933-939, Feb. 15 (1994).
Jonker et al., Br. J of Pharmacol., 127:43-50 (1999).
Zamora et al., Mol. Pharmacol., 33:454-462 (1988).
Lazarus Lawrence H.
Salvadori Severo
Leydig , Voit & Mayer, Ltd.
Lukton David
The United States of America as represented by the Department of
Weber Jon
LandOfFree
Dmt-Tic di-and tri-peptidic derivatives and related... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dmt-Tic di-and tri-peptidic derivatives and related..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dmt-Tic di-and tri-peptidic derivatives and related... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3398797